Make an Appointment

Ask a Question
Refer a Patient

1.877.CALL NJH
(877.225.5654)

Investigation of Reduced Interferon Responses in Peripheral Blood Mononuclear Cells of Participants with Atopic Dermatitis and a History of Eczema Herpeticum

Trial Location:
Main Campus, Denver, CO
Principal Investigator:

Mark Boguniewicz, MD
Donald Y.M. Leung, MD, PhD

Trial Sponsor(s):

NIH - DAIT

Trial Objective:

The purpose of this study is to is to determine why some individuals with atopic dermatitis are at higher risk for skin infections. Study involves 1 possibly 2-3 visits.

Compensation:

Provided

Who Can Participate:

Qualifications include males and females ages 6-65, diagnosis of atopic dermatitis.

Enrollment:

Active Clinical Trials Currently Recruiting

How to Participate:

For more information, contact Trish Taylor, NP at 303.398.1067 or Judy Lairsmith at 303.270.2413 or complete the form below.



Request More Information
*
*
*
*